Press

We will be happy to help you, if you

  • are interested in our opinion on the development of the regulation of the capital market or corporate governance;
  • need background-information on current share and capital market topics;
  • have statistical questions on shares and capital markets;
  • need to revert to our specialized capital market knowledge in any  other manner.

Media contact:

Dr. Uta-Bettina von Altenbockum: 
Head of Public Relations
Phone +49 69 92915-47
presse@dai.de

Following the German government's investment in the biotechnology company CureVac, known as the vaccine platform and currently the leader in the development of a vaccine against Covid-19, the company is now planning an IPO in New York. This example shows that Germany is still not an attractive location for IPOs of young growth companies and that politicians finally need to act.

 Download